glp-1 news november 3 2025 Novo cuts prices 70%, but semaglutide revenue could grow in 2026 GLP-1 drugs can be ‘too

As research progresses, the initiation of a phase 3 clinical trial to further evaluate its efficacy and safety remains on the horizon, signaling the next step in its development

Reddit is also full of threads with people on GLP-1s discussing how they feel weak as a result of muscle loss

Recent studies have demonstrated that a medication commonly prescribed for type 2 diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1RA), plays a role in facilitating retinal neuroprotection, which, in turn, may prevent glaucoma development and progression

This targeted microbiome approach reflects growing research connecting gut health with metabolic balance and long-term wellness

This meal balances lean protein with complex carbohydrates from sweet potatoes, which are high in fiber and gentle on digestion